2Kel er G. Embryonic stem celldifferentiation:emergence of a new era in biology and medicine[J].{H}Genes and development,2005,(10):1129-1155.
3Donovan PJ,Gearhart J. The end of the beginning for pluripotent stem cells[J].{H}NATURE,2001,(6859):92-97.
4Kel er G,Kennedy M,Papayannopoulou T. Hematopoietic commitment during embryonic stem celldifferentiation in culture[J].{H}Molecular and Cellular Biology,1993,(01):473-486.
5McClanahan T,Dalrymple S,Barkett M. Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells[J].{H}Blood,1993,(11):2903-2915.
6Schmitt RM,Bruyns E,Snodgrass HR. Hematopoietic development of embryonic stem cells in vitro:cytokine and receptor gene expression[J].{H}Genes and development,1991,(05):728-740.
7Johansson BM,Wiles MV. Evidence for involvement of activinA and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development[J].{H}Molecular and Cellular Biology,1995,(01):141-151.
8Sato N,Meijer L,Skaltsounis L. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor[J].{H}Nature Medicine,2004,(01):55-63.
